Search Results for "Dabur Sanat Pharma"

08:10 EDT 30th July 2015 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

OxyContin

OxyContin, an narcotic <!--LGfEGNT2Lhm-->analgesic produced by Purdue Pharma LP, nets $3m in <!--LGfEGNT2Lhm-->sales annually, placing it 8th in the world for annual sales. OxyContin i...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Boehringer Ingelheim

<!--LGfEGNT2Lhm-->Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.&...

Matching News

Endo’s Purchase of Par Pharma Shakes up the Industry

US Pharma M&A activity has yet to show any signs of a slowdown after the $8.1bn exit of Par Pharma by TPG to Endo was announced on Monday. The US Pharma industry has seen 39 deals valued at US$ 77...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Kaldi Pharma partners A2a/A1 antagonist with CleveXel Pharma

Kaldi Pharma, a special-purpose financing vehicle concurrently created by Domain Therapeutics SA, licensed CleveXel Pharma worldwide rights to the preclinical A2a/A1 antagonist CVXL0069 (formerly DT09...

Is India's Zyg Pharma on the block?

The privately owned Encore group of India may be looking at roping in a strategic equity partner or more for one of its pharma outfits, Zyg Pharma - a leading contract manufacturer of dermatology prod...

Big pharma to add $60bn in sales by 2024

Big pharma companies are set to grow their revenues by a modest 1.3% a year over the next 10 years, and oncology will slip from the top spot as the most lucrative therapy area. So says a new report on...

Eris Pharma acquires entire stake of Aurobindo Pharma unit

Aurobindo Pharma sold all of its stake in its Australian subsidiary to Eris Pharma Australia to focus on the U.S.  -More- 

Innate Pharma – therapeutic antibodies

Innate Pharma is a biopharma company developing therapeutic antibodies for the treatment of cancer and inflammatory diseases. Innate Pharma – therapeutic antibodies Innate Pharma is a leader in ...

Adjust your mawashi! It's Big Pharma Europe vs US II, Sumo-style

It's the next phase of Big Pharma US versus Big Pharma Europe. This time it's down to the dojo for some head-to-head pharma Sumo.

Matching PubMed Articles

Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.

Hélène Montpetit has a Bachelor of Science in Biochemistry from the University du Québec at Montreal. For the past 15 years, she has worked in the bioanalysis field in CROs environment as well as i...

10 years after implementation of TRIPS obligations in India.

The Patent (Amendment) Act of 2005 enforced after TRIPS raises many issues which hinder growth of Indian pharma companies. To tackle this, Indian pharma companies doubled their R&D expenditure and bec...

Pharmaceutical industry, academia and patient advocacy organizations: What is the recipe for synergic (win-win-win) collaborations?

Biological complexity and the need for highly differentiated medicines means that drug discovery and development have become increasingly challenging and expensive. Thus, new paradigms for research an...

Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology To Improve in Silico pKa Prediction.

In a unique collaboration between a software company and a pharmaceutical company, we were able to develop a new in silico pKa prediction tool with outstanding prediction quality. An existing pKa pred...

"Annual pharma statistics" as a health information system application in Iranian pharmaceutical sector.

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement